Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii
- PMID: 37231267
- DOI: 10.1038/s41589-023-01349-8
Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii
Abstract
Acinetobacter baumannii is a nosocomial Gram-negative pathogen that often displays multidrug resistance. Discovering new antibiotics against A. baumannii has proven challenging through conventional screening approaches. Fortunately, machine learning methods allow for the rapid exploration of chemical space, increasing the probability of discovering new antibacterial molecules. Here we screened ~7,500 molecules for those that inhibited the growth of A. baumannii in vitro. We trained a neural network with this growth inhibition dataset and performed in silico predictions for structurally new molecules with activity against A. baumannii. Through this approach, we discovered abaucin, an antibacterial compound with narrow-spectrum activity against A. baumannii. Further investigations revealed that abaucin perturbs lipoprotein trafficking through a mechanism involving LolE. Moreover, abaucin could control an A. baumannii infection in a mouse wound model. This work highlights the utility of machine learning in antibiotic discovery and describes a promising lead with targeted activity against a challenging Gram-negative pathogen.
© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.
Comment in
-
A new antibiotic for A. baumannii.Nat Rev Drug Discov. 2023 Jul;22(7):538. doi: 10.1038/d41573-023-00090-0. Nat Rev Drug Discov. 2023. PMID: 37286781 No abstract available.
Similar articles
-
AI-driven drug discovery: Exploring Abaucin as a promising treatment against multidrug-resistant Acinetobacter baumannii.Health Sci Rep. 2024 Jun 4;7(6):e2150. doi: 10.1002/hsr2.2150. eCollection 2024 Jun. Health Sci Rep. 2024. PMID: 38841115 Free PMC article.
-
Resistance mechanisms of tigecycline in Acinetobacter baumannii.Front Cell Infect Microbiol. 2023 May 9;13:1141490. doi: 10.3389/fcimb.2023.1141490. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37228666 Free PMC article. Review.
-
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.mBio. 2022 Feb 22;13(1):e0351721. doi: 10.1128/mbio.03517-21. Epub 2022 Jan 11. mBio. 2022. PMID: 35012353 Free PMC article.
-
A Deep Learning Approach to Antibiotic Discovery.Cell. 2020 Feb 20;180(4):688-702.e13. doi: 10.1016/j.cell.2020.01.021. Cell. 2020. PMID: 32084340 Free PMC article.
-
Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.Folia Histochem Cytobiol. 2008;46(3):257-67. doi: 10.2478/v10042-008-0056-x. Folia Histochem Cytobiol. 2008. PMID: 19056528 Review.
Cited by
-
The Structural and Molecular Mechanisms of Mycobacterium tuberculosis Translational Elongation Factor Proteins.Molecules. 2024 Apr 29;29(9):2058. doi: 10.3390/molecules29092058. Molecules. 2024. PMID: 38731549 Free PMC article. Review.
-
Combinatorial discovery of antibacterials via a feature-fusion based machine learning workflow.Chem Sci. 2024 Mar 26;15(16):6044-6052. doi: 10.1039/d3sc06441g. eCollection 2024 Apr 24. Chem Sci. 2024. PMID: 38665528 Free PMC article.
-
Massively parallel combination screen reveals small molecule sensitization of antibiotic-resistant Gram-negative ESKAPE pathogens.bioRxiv [Preprint]. 2024 Mar 26:2024.03.26.586803. doi: 10.1101/2024.03.26.586803. bioRxiv. 2024. PMID: 38585790 Free PMC article. Preprint.
-
Escherichia coli has an undiscovered ability to inhibit the growth of both Gram-negative and Gram-positive bacteria.Sci Rep. 2024 Mar 28;14(1):7420. doi: 10.1038/s41598-024-57996-x. Sci Rep. 2024. PMID: 38548840 Free PMC article.
-
Supercharged precision killers: Genetically engineered biomimetic drugs of screened metalloantibiotics against Acinetobacter baumanni.Sci Adv. 2024 Mar 22;10(12):eadk6331. doi: 10.1126/sciadv.adk6331. Epub 2024 Mar 22. Sci Adv. 2024. PMID: 38517956 Free PMC article.
References
-
- Antunes, L. C. S., Visca, P. & Towner, K. J. Acinetobacter baumannii: evolution of a global pathogen. Pathog. Dis. 71, 292–301 (2014). - PubMed
-
- 2020 Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis (World Health Organization, 2021); https://www.who.int/publications/i/item/9789240021303
-
- Walsh, C. Where will new antibiotics come from? Nat. Rev. Microbiol. 1, 65–70 (2003). - PubMed
-
- Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I. & Miller, A. A. ESKAPEing the labyrinth of antibacterial discovery. Nat. Rev. Drug Discov. 14, 529–542 (2015). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources